NDC 72786-102

OXBRYTA

Voxelotor

OXBRYTA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Global Blood Therapeutics Inc.. The primary component is Voxelotor.

Product ID72786-102_0f829f12-5b00-4e7f-9261-377702f5a2a3
NDC72786-102
Product TypeHuman Prescription Drug
Proprietary NameOXBRYTA
Generic NameVoxelotor
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-11-25
Marketing CategoryNDA /
Application NumberNDA213137
Labeler NameGlobal Blood Therapeutics Inc.
Substance NameVOXELOTOR
Active Ingredient Strength300 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72786-102-02

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-102-02)
Marketing Start Date2022-10-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "OXBRYTA" or generic name "Voxelotor"

NDCBrand NameGeneric Name
72786-101OXBRYTAVoxelotor
72786-102OXBRYTAVoxelotor
72786-111OXBRYTAVoxelotor

Trademark Results [OXBRYTA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OXBRYTA
OXBRYTA
88415216 not registered Live/Pending
Global Blood Therapeutics, Inc.
2019-05-03
OXBRYTA
OXBRYTA
87721060 not registered Live/Pending
Global Blood Therapeutics, Inc.
2017-12-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.